464 2SMALL (NCT04253145) phase I part: lurbinectidine (LUR) in combination with atezolizumab (ATZ) for second line extensive stage small cell lung cancer (ES-SCLC) patients (pts) J Immunother Cancer.

The National Institute for Health and Care Excellence (NICE) has issued a draft guidance recommending GSK’s Blenrep (belantamab mafodotin) in combination with bortezomib and dexamethasone (BVd) for ...

Here are nine second-year players who need to step up this fall after rough rookie seasons: Caleb Williams, QB, Chicago Bears What's left to say about one of the most tumultuous starts in some ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology ...

SAN FRANCISCO and SUZHOU, China, June 5, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...

Rudin C, Mountzios G, Sun L, et al. Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304. ASCO 2025. May 30 ...

REC has received approval from the Central government to raise funds through deep-discount bonds for a second time in less than a year, a government document dated May 30 showed.. REC has until ...

LBA8008Background: Tarlatamab, a bispecific T-cell engager (BiTE) immunotherapy, demonstrated promising activity in patients (pts) with previously treated SCLC in phase 1/2 trials. ... (CTx) as second ...

A Vancouver Canucks second line center target is officially off the market ahead of the opening of free agency in a little less than four weeks from today. It's going to be an interesting offseason ...

This US Mobile Deal Will Get You a Second Line Completely Free. Ayomide Sadiq. June 3, 2025. 0. 0. 0. 0. 0. 0. ... Both the regular line and the free line have to be ported in from another network.